evidence-based systematic review: thickened liquids as a … · 2011-02-16 · asha's national...
TRANSCRIPT
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Thickened Liquids as a Treatment for Children with Dysphagia and Associated Adverse Effects: A Systematic Review
Supplementary Materials
Table summarizing the participant characteristics of studies examining the effects of thickened liquids in children with dysphagia (Clinical Question1).
Table summarizing the findings from studies examining the effects of thickened liquids in children with dysphagia (Clinical Question1).
Table summarizing the participant characteristics of studies examining adverse effects (Clinical Question 2).
Table summarizing the findings from studies examining adverse effects (Clinical Question 2).
Quality indicators of the included studies.
Detailed search methodology.
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Participant Characteristics of Studies Examining the Effects of Thickened liquids in Children with Dysphagia (Clinical Question1)
Citation Total N (number available for analysis)
Mean Age (Range), mo
Gender Medical Diagnosis Weight Description of Swallowing Disorder/Assessment
Medications
Mercado-Deane et al,20
2001
126 (120) Participants < 12 mos (NR)
NR Suspected GER-additional diagnoses included prematurity, esophageal atresia, bronchopulmonary dysplasia, neurologic abnormality, or congenital heart disease
NR MBSS with thin liquids, thick liquids, and pureed food revealed tracheal aspiration or laryngeal penetration
NR
Khoshoo et al,23 2001
9 NR (3-12) NR Neurologically intact, clinically stable infants with RSV bronchiolitis and dysphagia including laryngeal penetration,tracheal penetration,and aspiration
NR VFSS with thin and thickened liquids
NR
Sheikh et al,242001
13 (9) 5.4 (NR) F= 4 M= 9
Dysphagia with silent chronic aspiration and recurrent respiratory symptoms
Mean weight 7.5 kg- allpercentiles for weight were between 25-50
VFSS to assess oral, pharyngeal and esophageal phases of swallow with thin, semi-thick, and thick consistencies. All participants demonstrated direct aspiration on VFSS.
Asthma medications continued during study
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Kuroki et al,25
19962 Participant 1:
2 mosParticipant 2: 1 mo
F=2 Intractable wheezing Participant 1 (at birth): 2654 gParticipant 2 (at birth): 3218 g
MBSS revealed nasopharyngeal reflux and cricopharyngeal incoordination.
Participant 2 occasionally given an expectorant and bronchodilator.
Frazier and Friedman,26
1996
19 (10) 24 (3-47) F= 3 M=16
Down syndrome and dysphagia
NR MBSS with thin liquids, thick liquids, puree, and solids (based on developmental level) -examined oral preparation, reflex initiation, pharyngeal clearing, aspiration, and cricopharyngeal screening
None reported
Schroeder et al,27 2008
52 (12) 8.2 (1 – 96) F= 22 M= 30
Severe laryngomalacia. Some also diagnosed with respiratory distress or failure to thrive.
NR VFSS was performed to confirm or deny post-surgical aspiration.
NR
Abbreviations: GER, gastroesophageal reflux; MBSS, modified barium swallow study; NR, not reported; RSV, respiratory syncytial viral, VFSS, videofluorscopic swallow study.
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Findings from Studies Examining the Effects of Thickened liquids in Children with Dysphagia (Clinical Question1)
Citation Thickener Composition
Amount of Thickener
Treatment Duration Outcome Measures and Major Findings Status with thickened liquids compared to thin liquids.
Other Related Findings
Mercado-Deane et al20
2001
Rice cereal 1 tblsp rice cereal/ oz thin liquid
Evaluation only Tracheal aspiration (n=89) Infants unable to swallow thicker consistencies were placed on tube feedings (n=32) until successful, safe swallowing was demonstrated on repeat MBSS. Swallowing usually improved by one year of age unless the infant presented with severe neurologic dysfunction
Eliminated 42% (37/89)
No change 39% (35/89)
Laryngeal penetration 19% (17/89)
Laryngeal penetration (n=31)
Eliminated 71% (22/31)
No change 29% (9/31)
Khoshoo et al,23 2001
Rice cereal 4g/30 mL of barium (85% barium sulfate suspension)
Evaluation only Laryngeal penetration (n=3) NoneEliminated 100% (3/3)
Tracheal penetration (n=2)
Eliminated 100% (2/2)
Aspiration (n=4)Eliminated 75% (3/4)
No change 25% ( 1/4)
Sheikh et al,24 2001
Rice cereal 1 tblsp rice cereal/oz of thin liquid barium (70%
3 mos Aspiration with thin liquids (n=7) 4 different participants aspirated thin, semi-thick, and thick Eliminated 100% (7/7)
ASHA's National Center for Evidence-Based Practice in Communication Disorders
concentrated: Barosperse barium sulfate suspension)
Aspiration with thin and semi-thick consistencies (n=2) consistencies and received tube feedings- aspiration resolved for all at 9-mo follow-up
Eliminated 100% (2/2)
Kuroki et al,25 1996
Corn starch NR Participant 1: NRParticipant 2: ≥ 1 mo
Nasopharyngeal reflux Both infants demonstrated normal growth and development at follow-up
Participant 1 Eliminated at 10-mo follow-up MBSS
Participant 2 Eliminated at 6-mo follow-up MBSS
Intractable wheezing
Participant 1 Eliminated
Participant 2 Eliminated
Frazier andFriedman,26
1996
NR Varied based on oral-motor development
Evaluation only Delayed swallow with thin liquids (n=10) NoneNo change 80% (8/10)
Improved 10% (1/10)
Eliminated 10% (1/10)
Aspiration with thin liquids (n=7)Eliminated 71% (5/7)
No change 29% (2/7)
No aspiration with thin liquids (n=3)
Worsened 33% (1/3)
Schroeder et al,27 2008
NR NR 7-18 mo Post-operative aspiration with thin liquids (n=12) None
Eliminated with thickened feeds
50% (6/12)
No change with thickened feeds
50% (6/12: participants went on to receive NG tube feedings and thickened feeds)
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Aspiration with thickened liquids (n=6: same participants as no change with thickened feeds group)
Eliminated with 4 mos of NG tube feedings plus 6-18mos of thickened feeds
100% (6/6)
Abbreviations: MBSS, modified barium swallow study; NG, nasogastric; NR, not reported or calculable.
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Participant Characteristics of Studies Examining Adverse Effects (Clinical Question 2)
Citation N (number available for analysis)
Mean Age (Range) Gender Medical diagnosis Mean weight Reported medications
Miyazawa et al,28
2008TF 1= 9TF 2= 9
11.7 y (NR) F= 2 M=16
Cerebral palsy and GERD. All subjects received enteral feeds (NG tube)
NR- 2/18 were of average weight the rest were below the 3rd percentile
Some participants received acid suppressors or prokinetics (Gasmotin) during study
Vanderhoof et al,29 2003
SF = 49TF = 55 (54)
SF:58 days (NR)TF:61 days (NR)
SF:F=23M= 26
TF:F=28M=27
Regurgitant GER SF = 5023 gTF= 5207 g
Pharmacological intervention as needed:Ranitidine any time after day 7/8Cisapride any time after day 14/15Three babies received pharmacotherapy: TF group = 2; SF group = 1
Vivatvakin andBuachum30 2003
20 13.4 wks (NR) F= 8 M= 12
Full-term infants with non-pathological GER (accompanied by regurgitation)
4943 g Infants developing gastroparesis received domperidone or cisapride
Chao andVandenplas31 2007
SF= 40TF = 41
SF: 90.5 days (NR)TF: 90.2 days (NR)
F= 39 M=42
Frequent regurgitation/vomiting
SF = 5466.1 gTF = 5423.4 g
None
Moukarzel et al,32
2007SF = 38 (32)TF = 36 (28)
3.24 mos (NR) F= 34 M= 40
Healthy term infants diagnosed with GER
NR None
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Xinias et al,33
2003SF = 28TF = 28
3.1 mos (NR) F= 26 M= 30
Mild to moderate GER accompanied by recurrent vomiting
NR None
Levtchenko et al,34 1998
SF= 20 TF = 20
newborns NR Healthy infants SF = 3328 gTF=3472 g
None
Miyazawa et al,35
200720 36 days (NR) F= 12
M=8Frequent regurgitation/vomiting GER
4357.2 g None
Miyazawa et al,36
2004TF 1= 16TF 2= 14 (11)
TF 1:130.9 days (NR)TF 2:124.5 days (NR)
F=16M=14
Uncomplicated GER (daily regurgitation)
TF 1= 6726 gTF 2= 6185 g
None
Hegar et al,37 2008 SF =20 TF 1= 20TF 2= 20
SF: 47.1 days (NR)TF 1:48.7 days (NR)TF 2:46.2 days (NR)
F=38 M=22
Healthy term infants with frequent regurgitation/vomiting
SF = 5037 gTF 1 = 5010 gTF 2 = 4855 g
None
Orenstein et al,38
198720 NR (4−24 wks) NR Gastroesophageal
reflux – one infant was also diagnosed with Pierre Robin syndrome
NR None
Orenstein et al,39
199225 Median= 7.5 weeks (7
weeks corrected for gestational age
NR GER NR None
Ramirez-Mayans et al,40 2003
TF 1= 24TF 2 = 28
TF 1: 1.93 mos (NR)TF 2: 2.52 mos (NR)
F= 21 M=31
Non-pathological GER TF 1 = 4670 gTF 2 = 4950 g
None
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Wu et al,412001 30 3.78 mos (NR) F= 16 M=14
Simple GER 6587 g None
Miyazawa et al,42
2006- Phase 2TF 1= 14TF 2= 13
NR NR for Phase 2
Recurrent regurgitation but no symptoms indicating GER-related complications
NR None
Penna et al,43 2003 SF =48 TF =52
NR (0-12 mos) NR Uncomplicated GER NR None
Note: g= grams; GER= gastroesophageal reflux; NR= not reported or calculable; SF = standard formula group; TF = thickened formula group
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Outcomes from Studies Examining Adverse Effects (Clinical Question 2)
Citation Formula/thickening agent (Brand)
Treatment frequency and duration
Feeding method
Outcome measures and major findings Related findings
Statistical significance
Effect size (95% CI)
Miyazawa et al,282008
SF: enteral formula (K4A)
TF 1 -low pectin: Enteral formula (K4A):pectin liquid= 3:1
TF 2-high pectin: Enteral formula (K4A):pectin liquid= 2:1
8 wks-4 wks on a pectin diet (high or low) and 4 wks on a non-pectin diet
Enteral feeds (NG)
Median cough score – TF 1 vs. SF: P<.05(favoring TF 1)
NR None
Median cough score – TF 2 vs. SF: P<.05 (favoring TF 2)
NR
Vanderhoof et al,29 2003
SF: commerciallyavailable cow-milk-based infant formula (NR)
TF: pregelatinized rice starch (Enfamil AR)
5 wks Bottle Choke/gag/cough rate-end of week 1: P<05(favoring TF)
NR 17 (13% of TF group and 20% of SF group; NS) babies discontinued study due to reasons related to the formula -intolerance, failure to thrive, or parental election.
5 infants were discontinued for non-formula reasons- loss to follow-up, illness induced failure to consume adequate formula, and one serious adverse event.
Choke/gag/cough rate-end of study: P<.05(favoring TF)
NR
Constipation : NS at end of week 1 or at end of study
NR
Diarrhea: NS at end of week 1 or at end of study
NR
Incidence of serious adverse events: NS at end of week 1 or at end of study
NR
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Vivatvakin and Buachum,30
2003
SF: cow’s milk infant formula (NR)
TF: carob bean gum (NR)
4 wks-2 wks on SF and 2 wks on TF
Bottle Weight gain/wk: P< .01 (favoring TF)
d (repeated measures)= 1.04 (-58.65 4−5.18)
Colic rate: NSGastroparesis: NS
Less night coughing:P<.01 (favoring TF)
NR
Chao andVandenplas,31
2007
SF: strengthened regular formula: (Novalac 1)- 5measurements of formula/120ml water
TF: corn starch (InterNovolac AR)
2 mos for all feeds
Bottle Cough: NS NR 8 children were excluded from the study because they developed diarrhea or enteritis but the authors did not report which formula the children received.
Weight gain at 1 mo:P<.01 (favoring TF)
d=1.41 (0.91−1.88)
Weight gain at 2 mos: P<.01 (favoring TF)
d= 1.50 (0.99−1.98)
Moukarzel et al,32 2007
SF: regular infant formula (Wyeth)
TF : pregelatinized corn starch (Wyeth)
1 mo for all feeds
Bottle No adverse events were reported during the study
6 infants from SF group and 8 from TF group (NS) were excluded from the study post-randomization due to the development of GER symptoms that required medical treatment. These symptoms included excessive crying, dysphagia equivalent, refusal to eat, or inadequate weight gain.
Height: NS
Infant weight: NS NR
Xinias et al,33
2003SF: normal milk formula(NR)
TF: corn starch and an
4 wks Parents were told to continue the
Cough rate: NS d= 0 (-0.52− 0.52) Height: NS
No changes in stool consistency or frequency noted
ASHA's National Center for Evidence-Based Practice in Communication Disorders
increased amount of casein (NR)
nonmedical instructions for feeding and positioning that they had used prior to the study.
Weight: NS NR during the study
Levtchenko et al,34 1998
SF: (Nutrilon Premium)
TF : bean gum (Nutrilon AR)
13 wks for all feeds
Bottle Total weight gain: NS
NR Length gain: NS
Weight gain/day: NS
NR
Miyazawa et al,35 2007
SF: (Hagukumi)
TF: locust bean gum/SF= .35g/100 mL
2 wks -one wk of SF and one wk of TF
Bottle The authors reported that no infant had any complications during the test period.
TF resulted in significantly more bowel movements (P<.01) than control formula.
Weight gain over one week: NS
NR
Miyazawa et al,36 2004
SF: (Hagukumi)
TF 1: locust bean gum/SF = .45g/100 mL
TF 2: locust bean gum/SF= .35g/100 mL
2 wks- one wk of TF (1 or 2) and one wk ofSF
After 2 wks, families were supplied with2 months of preferred formula (TF or SF)
Bottle Authors reported that no infant had any complications during the study.
Bowel movements/day:TF 1: NSTF 2: P<.05Weight gain (g/d)
TF 1: NSNR
Weight gain (g/d)TF 2: P<.05
NR
Weight gain at 7 months of agereported as “similar”across all three groups: NR
TF 1vs. TF 2:d=-0.32 (-1.16− 0.55)(favoring TF 2)
TF1 vs. SF:d=0.69 (-0.4−1.71)(favoring TF 1)
ASHA's National Center for Evidence-Based Practice in Communication Disorders
TF2 vs. SF:d= 1.14 (-
0.1−2.22)(favoring TF 2)
Weight gain at 12 months of age reported as “similar”across all three groups: NR
TF 1vs TF 2:d=-0.33(-1.17−0.54)(favoring TF 2)TF1 vs. SF:d=0.39 (-0.67−1.41)(favoring TF 1)TF2 vs. SF:d= 0.79 (-0.39−1.87)(favoring TF 2)
Hegar et al,37
2008SF: NR
TF 1: rice cereal (Nestle)/SF= 5g /100mL
TF 2: bean gum (Nutrilon 1- AR)
4 wks for all feeds
Bottle Weight gain-TF 2 vs. standard: P<.05 (favoring TF 2)
d= 0.84 (0.18−1.47)
Authors reported that stool consistency and frequency did not differ between the groups during the intervention period.Weight gain-TF 2
vs. TF 1: P<0.01(favoring TF 2)
d= 2.87 (1.94−3.69)
Weight gain- SF vs. TF 1: NR
d= -1.91(-2.62− -1.13)(favoring SF)
Orenstein et al,38 1987
SF: radiolabeled infant formula (NR)
TF: dry rice cereal/SF=
Paired feedings separated by 48− 72 hrs to allow for
Fed by nipple with an enlarged hole1 infant fed
Cough rate during the postprandial period: NS
d= -0.44 (-1.06−0.2)(favoring SF)
None
ASHA's National Center for Evidence-Based Practice in Communication Disorders
15 ml/30 ml sufficient decay of radionuclide in the initial feeding -20 mins allotted for each feeding with identical fasting periods preceding each one
via gastrostomy tube1 infant became tired and finished her feeding through a nasogastric tube
Aspiration rate: No aspiration was detected in any of the infants
NR
Orenstein et al,39 1992
SF: infant’s usual formula (NR)
TF: dry rice cereal (Heinz) - 20 ml/kg of their usual formula mixed with 10 ml/kg of rice cereal
Two 30-min feedings- one with SF and one with TF
Bottle Cough salvos per hour (thickened > unthickened): P<.05
d= -0.35 (-0.9− 0.22)
None
Total coughs per hour (thickened > unthickened): P<.05
d= -0.34 (-0.89−0.22)
Number of coughs during feeding: NS
d= 0 [-0.55, 0.55]
After feeding (thickened > unthickened): P<.01
d= -0.38 (- 0.94−0.18)
Ramirez-Mayans et al,40
2003
TF 1: rice cereal (Wyeth)/SF=5g/100mL
TF 2: pre-gelatinized corn starch (Wyeth)
3 wks Bottle No reports of cough in either group. No dropouts were related to formulas
Three reports of constipation in TF 1 group and no reports of constipation in TF 2 group: NS
NR
Wu et al,41
2001SF: commercially available infant formula(NR)
TF - rice starch (NR)
1wk - allfeeds
Bottle No constipation or diarrhea reported in either group.
NR 13/30 showed hardening of stool pattern but not to adverse level
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Miyazawa et al,42 2006
SF: (Hagukumi)
TF 1: locust bean gum/SF= .45g/100 mL
TF 2: locust bean gum/SF= .35g/100 mL
2 wks- one wk on TF (1 or 2) and one wk on SF
Bottle Authors reported that TF caused no complications.
NR 1/14 in TF 1 group and 2/13 in TF 2 group reported an increase in bowel movements but none of the infants had severe diarrhea.
Penna et al,43
2003TF 1: regular formula for children 0-6 mos or > 6 mos thickened with corn starch.
TF 2: pre-gelatinized corn starch (Nan AR)
3 mos Bottle Authors stated that "no side effects associated with the use of the tested dietary regimen were verified"
NR None
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Table 6. Quality Indicators of Included Studies
Citation Clinical question
Study design Study protocola
Assessor blindinga
Sampling/allocationa
Evidence of treatment fidelitya
Significancea Precisiona Intention to treata
Mercado-Deane et al20
2001
1 Case series Adequate description of protocol
NR NR No evidence of treatment fidelity
P value neither reported nor calculable
Neither effect size nor confidence interval reported or calculable
NA
Khoshoo et al,23 2001
1 Case series Adequate description of protocol
NR Convenience sample/Hand-picked sample
No evidence of treatment fidelity
P value neither reported nor calculable
Neither effect size nor confidence interval reported or calculable
NA
Sheikh et al,24
20011 Case series Adequate
description of protocol
Assessors not blinded
Convenience sample/Hand-picked sample
No evidence of treatment fidelity
P value neither reported nor calculable
Neither effect size nor confidence interval reported or calculable
NA
Kuroki et al,25
19961 Case study Adequate
description of protocol
NR Convenience sample/Hand-picked sample
No evidence of treatment fidelity
P value neither reported nor calculable
Neither effect size nor confidence interval reported or calculable
NA
Frazier and Friedman,26
1996
1 Case series Inadequate description of protocol
Assessors not blinded
Convenience sample/Hand-picked
No evidence of treatment fidelity
P value neither reported nor calculable
Neithereffect size nor
NA
ASHA's National Center for Evidence-Based Practice in Communication Disorders
sample confidence interval reported or calculable
Schroeder et al,27 2008
1 Case series Inadequate description of protocol
NR NR No evidence of treatment fidelity
P value neither reported nor calculable
Neither effect size nor confidence interval reported or calculable
NA
Miyazawa et al,28 2008
2 Controlled trial-crossover design
Adequate description of protocol
Assessors blinded
Random sample inadequately described
No evidence of treatment fidelity
P value reported or calculable
Neither effect size nor confidence interval reported or calculable
NR
Vanderhoof et al,292003
2 Controlled trial
Adequate description of protocol
Assessors blinded
Random sample inadequately described
Evidence of treatment fidelity
P value reported or calculable
Neither effect size nor confidence interval reported or calculable
Not analyzed by intention to treat
Vivatvakin and Buachum,30
2003
2 Controlled trial-crossover design
Adequate description of protocol
NR NR No evidence of treatment fidelity
P value reported or calculable
Effect size and confidence interval reported or calculable
NR
Chao and Vandenplas,31
2007
2 Controlled trial
Adequate description of protocol
Assessors not blinded
Random sample inadequately described
No evidence of treatment fidelity
P value reported or calculable
Effect size and confidence interval reported or
Not analyzed by intention to treat
ASHA's National Center for Evidence-Based Practice in Communication Disorders
calculable
Moukarzel et al,32 2007
2 Controlled trial
Adequate description of protocol
Assessorsnot blinded
Random sample adequately described
No evidence of treatment fidelity
P value reported or calculable
Neither effect size nor confidence interval reported or calculable
Not analyzed by intention to treat
Xinias et al,33
20032 Controlled
trialAdequate description of protocol
NR Convenience sample/Hand-picked sample
No evidence of treatment fidelity
P value reported or calculable
Effect size and confidence interval reported or calculable
NR
Levtchenko et al,34 1998
2 Controlled trial
Adequatedescription of protocol
Assessors not blinded
Random sample inadequately described
Evidence of treatment fidelity
P value reported or calculable
Neither effect size nor confidence interval reported or calculable
NR
Miyazawa et al,35 2007
2 Controlled trial –crossover design
Adequate description of protocol
Assessors blinded
Random sample inadequately described
No evidence of treatment fidelity
P value reported or calculable
Neither effect size nor confidence interval reported or calculable
NR
Miyazawa et al,36 2004
2 Controlled trial-crossover design
Adequate description of protocol
NR Random sample inadequately described
No evidence of treatment fidelity
P value reported or calculable
Effect size and confidence interval reported or calculable
NR
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Hegar et al,37
20082 Controlled
trialAdequate description of protocol
Assessors not blinded
Random sample adequately described
No evidence of treatment fidelity
P value reported or calculable
Effect size and confidence interval reported or calculable
NR
Orenstein et al,38 1987
2 Controlled trial-crossover design
Adequate description of protocol
Assessors blinded
Random sample adequately described
No evidence of treatment fidelity
P value reported or calculable
Effect size and confidence interval reported or calculable
NR
Orenstein et al,39 1992
2 Controlled trial-crossover design
Adequate description of protocol
Assessors blinded
Random sample adequately described
No evidence of treatment fidelity
P value reported or calculable
Effect size and confidence interval reported or calculable
NR
Ramirez-Mayans et al,40
2003
2 Controlled trial
Adequate description of protocol
Assessors blinded
Random sample adequately described
No evidence of treatment fidelity
P value reported or calculable
Effect size and confidence interval reported or calculable
NR
Wu et al,41
20012 Controlled
trial-crossover design
Adequate description of protocol
Assessors not blinded
NR No evidence of treatment fidelity
P value neither reported nor calculable
Neithereffect size nor confidence interval reported or calculable
NR
Miyazawa et al,42 2006
2 Controlled trial-crossover design
Adequate description of protocol
Assessors not blinded
Random sample inadequately described
No evidence of treatment fidelity
P value neither reported nor calculable
Neither effect size nor confidence
NR
ASHA's National Center for Evidence-Based Practice in Communication Disorders
interval reported or calculable
Penna et al,43
20032 Controlled
trialAdequate description of protocol
NR Random sample inadequately described
No evidence of treatment fidelity
P value reported or calculable
Neither effect size nor confidence interval reported or calculable
NR
Abbreviations: NA, not applicable; NR, not reported.aBoldface indicates highest level of quality in that category.
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Thickened Liquids EBSR Search Methodology Electronic Databases Searched (24 Total):
PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) CINAHL (EBSCO) Health Source: Nursing (EBSCO) Psychology and Behavioral Sciences Collection (EBSCO) PsycINFO (EBSCO) Communication & Mass Media Complete (EBSCO) Education Research Complete (EBSCO) ComDisDome (CSA) CSA Neurosciences Abstracts ERIC (CSA) LLBA (CSA) CSA Social Services Abstracts ISI Web of Science Cochrane Library (Wiley) ScienceDirect SUMSearch (http://sumsearch.uthscsa.edu/) SpeechBITE (http://www.speechbite.com/) REHABDATA (http://www.naric.com/research/rehab/) TripDatabase (http://www.tripdatabase.com/) Latin American and Caribbean Center on Health Sciences Information (LILACS) (http://www.bireme.br/php/index.php?lang=en) NHS Evidence Health Information Resources (formerly National Library for Health) (http://www.library.nhs.uk/) HighWire Press International Bibliographic Information on Dietary Supplements (IBIDS) GoogleScholar
Keywords:
Dysphagia OR deglutition OR swallowing disorders Thickeners OR thickened liquids OR thickening agents Rice cereal OR xantham gum OR starch OR nectar OR honey OR gel OR consistency OR formula Gastroesophageal reflux (GER) OR gastroesophageal reflux disorder (GERD) OR motility disorders OR weight OR nutrition OR gut adhesion OR necrotising enterocolitis OR reflux OR colic OR intestinal obstruction OR diarrhea Hoarseness OR cough OR abdominal pain OR nausea OR aspiration pneumonia
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Expanded Keywords:
(("Deglutition"[Mesh] OR "Deglutition Disorders"[Mesh] OR swallow* OR dysphagi* OR deglutiti*) AND ("Nutritive Value"[Mesh] OR "Food Additives"[Mesh] OR "Foods, Specialized"[Mesh] OR thicken*)) (("Deglutition"[Mesh] OR "Deglutition Disorders"[Mesh] OR swallow* OR dysphagi* OR deglutiti*) AND ("Viscosity"[Mesh] OR "Cereals"[Mesh] OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR carobel OR hydra aid OR thick* OR thik OR consistenc*)) ("Deglutition Disorders/diet therapy"[Mesh] OR "Deglutition Disorders/rehabilitation"[Mesh] OR "Deglutition Disorders/therapy"[Mesh]) AND ("Nutritive Value"[Mesh] OR "Food Additives"[Mesh] OR "Foods, Specialized"[Mesh] OR "Cereals"[Mesh] OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR carobel OR hydra aid OR thick* OR thik OR consistenc*) ("Deglutition"[Mesh] OR "Deglutition Disorders"[Mesh] OR swallow* OR dysphagi* OR deglutiti*) AND ("Gastrointestinal Motility"[Mesh] OR "Gastrointestinal Diseases"[Mesh] OR "Signs and Symptoms, Digestive"[Mesh] OR "Irritable Mood"[Mesh] OR "Nutritive Value"[Mesh] OR "Nutritional Status"[Mesh] OR "Failure to Thrive"[Mesh] OR "Feeding Methods"[Mesh] OR "Weight Gain"[Mesh] OR "Airway Obstruction"[Mesh] OR "Respiration Disorders"[Mesh] OR "Respiratory Aspiration"[Mesh] OR liquid transfer OR hydration OR hydrate*) AND ("Viscosity"[Mesh] OR "Cereals"[Mesh] OR "Food Additives"[Mesh] OR "Foods, Specialized"[Mesh] OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR carobel OR hydra aid OR thick* OR thik OR consistenc*)’ ("Gastrointestinal Motility"[Mesh] OR "Gastrointestinal Diseases"[Mesh] OR "Signs and Symptoms, Digestive"[Mesh] OR "Irritable Mood"[Mesh] OR "Nutritive Value"[Mesh] OR "Nutritional Status"[Mesh] OR "Failure to Thrive"[Mesh] OR "Feeding Methods"[Mesh] OR "Weight Gain"[Mesh] OR "Airway Obstruction"[Mesh] OR "Respiration Disorders"[Mesh] OR "Respiratory Aspiration"[Mesh] OR liquid transfer OR hydration OR hydrate*) AND (thick* OR thik*) ("Gastrointestinal Motility"[Mesh] OR "Gastrointestinal Diseases"[Mesh] OR "Signs and Symptoms, Digestive"[Mesh] OR "Irritable Mood"[Mesh] OR "Nutritive Value"[Mesh] OR "Nutritional Status"[Mesh] OR "Failure to Thrive"[Mesh] OR "Feeding Methods"[Mesh] OR "Weight Gain"[Mesh] OR "Airway Obstruction"[Mesh] OR "Respiration Disorders"[Mesh] OR "Respiratory Aspiration"[Mesh] OR liquid transfer OR hydration OR hydrate*) AND ("Viscosity"[Mesh] OR "Cereals"[Mesh] OR "Food Additives"[Mesh] OR "Foods, Specialized"[Mesh] OR carob OR pectin OR cellulose OR rice OR gum OR starch OR tapioca OR carobel OR hydra aid OR consistenc*) NOT “skin* thickness”
ASHA's National Center for Evidence-Based Practice in Communication Disorders
(("Gastrointestinal Motility"[Mesh] OR "Gastrointestinal Diseases"[Mesh] OR "Signs and Symptoms, Digestive"[Mesh] OR "Irritable Mood"[Mesh] OR "Nutritive Value"[Mesh] OR "Nutritional Status"[Mesh] OR "Failure to Thrive"[Mesh] OR "Feeding Methods"[Mesh] OR "Weight Gain"[Mesh] OR "Airway Obstruction"[Mesh] OR "Respiration Disorders"[Mesh] OR "Respiratory Aspiration"[Mesh] OR "Weight Loss"[Mesh] OR "Dehydration"[Mesh] OR "Failure to Thrive"[Mesh] OR liquid transfer OR hydration OR hydrate*) AND ("Viscosity"[Mesh] OR "Cereals"[Mesh] OR "Food Additives"[Mesh] OR "Foods, Specialized"[Mesh] OR carob OR pectin OR cellulose OR rice OR gum OR starch OR tapioca OR carobel OR hydra aid OR consistenc* OR enfamil*) NOT “skin* thickness”) AND thick* (thickener[All Fields] OR thickened[All Fields] OR thik[All Fields]) AND (dyspaghia[All Fields] OR ("deglutition"[MeSH Terms] OR "deglutition"[All Fields]) OR deglutitive[All Fields] OR ("deglutition"[MeSH Terms] OR "deglutition"[All Fields] OR "swallowing"[All Fields])) NOT "skinfold thickness"[All Fields] AND ("humans"[MeSH Terms] AND English[lang] AND ("infant"[MeSH Terms] OR "child"[MeSH Terms] OR "adolescent"[MeSH Terms])) ("Deglutition Disorders/diet therapy"[MeSH Terms] OR "Deglutition Disorders/therapy"[Mesh]) AND "Viscosity"[Mesh] (("Deglutition"[Mesh] OR "Deglutition Disorders"[Mesh] OR swallow* OR dysphagi* OR deglutiti*) AND ("Treatment Outcome"[Mesh] OR "Feeding Behavior"[Mesh])) MM = Major concept MH = Major Heading (MH "Impaired Swallowing (NANDA)") or (MH "Deglutition") or (MH "Deglutition Disorders") AND (cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR carobel OR hydra aid OR thick* OR thik OR consistenc* OR viscos*) (MH "Deglutition Disorders") AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil) ((MH "Dehydration") or (MH "Respiratory Tract Diseases+") or (MH "Aspiration") or (MH "Pneumonia, Aspiration") or (MH "Intestinal Diseases+") or (MH "Gastrointestinal Motility+") or (MH "Diarrhea") or (MH "Body Weight Changes+") or (MH "Colic+") or (MH "Growth Disorders+")) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil) (dysphagi* OR deglutition OR deglutitive OR swallow*) AND (physiol* OR efficiency OR liquid transfer OR aspiration OR aspirated OR feeding time) (dysphagi* OR deglutition OR deglutitive OR swallow*) AND (oral feed*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*)
ASHA's National Center for Evidence-Based Practice in Communication Disorders
(dysphagi* OR deglutition OR deglutitive OR swallow*) AND (weight OR growth OR thrive) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (dysphagi* OR deglutition OR deglutitive OR swallow*) AND (hydrat* OR dehydr* OR aspirat* OR bronchitis OR brochi*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (enterocolitis OR gut adhesion OR obstruction OR diarrhea OR aspirat* OR cough* OR colic OR weight OR thrive OR dehydrat*) AND (thick* OR thik*) DE = Subject term DE "DEGLUTITION disorders" AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (dysphagi* OR deglutition OR deglutitive OR swallow*) AND (physiol* OR efficiency OR liquid transfer OR aspiration OR aspirated OR feeding time) (dysphagi* OR deglutition OR deglutitive OR swallow*) AND (oral feed*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (dysphagi* OR deglutition OR deglutitive OR swallow*) AND (weight OR growth OR thrive) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (dysphagi* OR deglutition OR deglutitive OR swallow*) AND (hydrat* OR dehydr* OR aspirat* OR bronchitis OR brochi*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) DE "GASTROESOPHAGEAL reflux in children" AND (thick* OR thik*) (DE "DEGLUTITION DISORDERS IN CHILDREN" AND PT "ACADEMIC JOURNAL") OR (DE "DEGLUTITION DISORDERS IN CHILDREN --*" AND PT "ACADEMIC JOURNAL") (DE "Dysphagia" or DE "Feeding Disorders" or DE "Pharyngeal Disorders" or DE "Swallowing") AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR
ASHA's National Center for Evidence-Based Practice in Communication Disorders
carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (DE "Dysphagia" or DE "Feeding Disorders" or DE "Pharyngeal Disorders" or DE "Swallowing") AND (physiol* OR efficiency OR liquid transfer OR aspiration OR aspirated OR feeding time) (DE "Dysphagia" or DE "Feeding Disorders" or DE "Pharyngeal Disorders" or DE "Swallowing") AND (oral feed*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (DE "Dysphagia" or DE "Feeding Disorders" or DE "Pharyngeal Disorders" or DE "Swallowing") AND (weight OR growth OR thrive) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (DE "Dysphagia" or DE "Feeding Disorders" or DE "Pharyngeal Disorders" or DE "Swallowing") AND (hydrat* OR dehydr* OR aspirat* OR bronchitis OR brochi*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) DE = Descriptor ("dysphagia" or "swallowing" or "pediatric swallowing disorders" or "swallowing disorders") AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) DE="deglutition disorders diet therapy" ("dysphagia" or "swallowing" or "pediatric swallowing disorders" or "swallowing disorders") AND (physiol* OR efficiency OR liquid transfer OR aspiration OR aspirated OR feeding time) AND (DE=("infant newborn") or DE=("infant") or DE=("adolescent") and DE=("child") and DE=("child preschool")) ("dysphagia" or "swallowing" or "pediatric swallowing disorders" or "swallowing disorders") AND (oral feed*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) ("dysphagia" or "swallowing" or "pediatric swallowing disorders" or "swallowing disorders") AND (weight OR growth OR thrive) AND (thick* OR thik* OR carobel OR
ASHA's National Center for Evidence-Based Practice in Communication Disorders
hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) ("dysphagia" or "swallowing" or "pediatric swallowing disorders" or "swallowing disorders") AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) AND (DE=("infant newborn") or DE=("infant") or DE=("adolescent") and DE=("child") and DE=("child preschool")) DE="deglutition disorders therapy" AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) DE=("dysphagia" or "esophageal diseases") AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) ((enterocolitis OR gut adhesion OR obstruction OR diarrhea OR aspirat* OR cough* OR colic OR weight OR thrive OR dehydrat*) AND (thick* OR thik*)) and (DE=("children" or "adolescence" or "infants" or "juveniles" or "pediatrics")) (MeSH descriptor “Deglutition Disorders” explode all trees) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (MeSH descriptor “Deglutition Disorders” explode all trees) AND (physiol* OR efficiency OR liquid transfer OR aspiration OR aspirated OR feeding time) (MeSH descriptor “Deglutition Disorders” explode all trees) AND (oral feed*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (MeSH descriptor “Deglutition Disorders” explode all trees) AND (weight OR growth OR thrive) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (MeSH descriptor “Deglutition Disorders” explode all trees) AND (hydrat* OR dehydr* OR aspirat* OR bronchitis OR brochi*) AND (thick* OR thik* OR carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca OR consistenc* OR viscos*) (thickened liquid) OR thickener
ASHA's National Center for Evidence-Based Practice in Communication Disorders
Target area: Dysphagia Intervention: Swallowing/feeding intervention Keyword: Thickened liquids Keyword: Thickener (thickener OR thickened liquid) AND (infant* OR neonat* OR child* OR adolescen*) thickened [Words] and thickener [Words] Anywhere in Text: thickener thickened Title & Abstract only: infant toddler child adolescent adolescence Anywhere in Text: carobel hydra-aid enfamil Title & Abstract only: infant toddler child adolescent adolescence Anywhere in Text: cereal carob pectin cellulose rice gum Title & Abstract only: swallowing dysphagia deglutition Anywhere in Text: starch tapioca consistency viscosity Title & Abstract only: swallowing dysphagia deglutition Carobel Enfamil infant +(thick thickener thickened thik) +(dysphagia deglutitive deglutition swallowing) Enterocolitis Thickener hydra aid +thick (thickened OR thickener) AND (infant* OR neonat* OR child* OR adolescen*) AND (treatment OR therapy) AND (swallow* OR dysphag* OR degluti*) -rat -cat -lamb -dog -hamster -mouse (thick OR thickened OR thickener) AND (carobel OR hydra-aid OR enfamil OR cereal OR carob OR pectin OR cellulose OR rice OR gum OR cornstarch OR starch OR tapioca) AND (infant* OR neonat* OR child* OR adolescen*) AND (treatment OR therapy) AND (swallow* OR dysphag* OR degluti*) -rat -cat -lamb -dog -hamster -mouse